Form 4: Chemours Director Livingston Satterthwaite Acquires Deferred Stock Units

Chemours Company Director Livingston Satterthwaite acquired 1,337 deferred stock units, equivalent to common stock, effective June 30, 2025, as part of a routine compensation grant.

Summary

• Director Livingston Satterthwaite of The Chemours Company (CC) acquired 1,337 Deferred Stock Units (DSUs).
• The transaction date for the acquisition of these DSUs was June 30, 2025.
• Each DSU is the economic equivalent of one share of Chemours' common stock.
• The DSUs have a stated price of $11.45 per unit.
• These deferred stock units will become payable upon the second calendar year following Satterthwaite's termination of service as a director.
• Following this reported transaction, Satterthwaite directly beneficially owns 1,337 Deferred Stock Units.

Sentiment

Score: 7

Explanation: The acquisition of deferred stock units by a director is generally a positive signal, indicating alignment of interests and long-term commitment, though it's a routine compensation event rather than a strategic announcement.

Positives

• The acquisition of deferred stock units by a director aligns their long-term interests with those of shareholders, as the value of the units is tied to the company's stock performance.
• Deferred stock units are a common form of equity compensation for directors, designed to encourage retention and focus on long-term value creation.

Risks

• The ultimate value realized from the deferred stock units is dependent on the future market price of Chemours' common stock, which could decline.
• The payout of the deferred stock units is contingent upon the director's termination of service, meaning the benefit is not immediately accessible.

Future Outlook

The acquisition of deferred stock units by a director suggests a long-term commitment and alignment with the company's future performance, as the units are payable upon termination of service.

Industry Context

Insider equity grants, such as deferred stock units, are standard practice across various industries to align management and director interests with shareholder value. This specific transaction reflects a common compensation structure for board members in publicly traded companies.

Comparison to Industry Standards

• The use of deferred stock units as director compensation is a common practice among U.S. public companies, aligning director incentives with long-term shareholder value.
• The specific number of units (1,337) and their value ($11.45 per unit) are typical for routine director compensation grants, though a detailed comparison would require examining compensation packages of directors at peer companies within the chemicals industry (e.g., DuPont, LyondellBasell, Dow Inc.).

Related Party Transactions

• The acquisition of deferred stock units by a director is a related party transaction, representing a form of compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The acquisition of DSUs by a director aligns their interests with shareholders, as the value of the units is tied to the company's stock performance, potentially encouraging decisions that enhance long-term shareholder value.

Next Steps

• The deferred stock units will become payable upon the second calendar year following the reporting person's termination of service as a director.

Key Dates

Recommendation

Keywords

Chemours, CC, Form 4, SEC filing, insider transaction, deferred stock units, DSU, director compensation, equity compensation, beneficial ownership, Livingston Satterthwaite